US20120325228A1 - Alkaloid composition for e-cigarette - Google Patents
Alkaloid composition for e-cigarette Download PDFInfo
- Publication number
- US20120325228A1 US20120325228A1 US13/493,132 US201213493132A US2012325228A1 US 20120325228 A1 US20120325228 A1 US 20120325228A1 US 201213493132 A US201213493132 A US 201213493132A US 2012325228 A1 US2012325228 A1 US 2012325228A1
- Authority
- US
- United States
- Prior art keywords
- composition
- alkaloid
- anatabine
- weight
- cigarette
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229930013930 alkaloid Natural products 0.000 title claims abstract description 99
- 150000003797 alkaloid derivatives Chemical class 0.000 title claims abstract description 85
- 239000000203 mixture Substances 0.000 title claims abstract description 82
- 239000003571 electronic cigarette Substances 0.000 title claims abstract description 30
- SOPPBXUYQGUQHE-JTQLQIEISA-N Anatabine Chemical compound C1C=CCN[C@@H]1C1=CC=CN=C1 SOPPBXUYQGUQHE-JTQLQIEISA-N 0.000 claims abstract description 58
- SOPPBXUYQGUQHE-UHFFFAOYSA-N Anatabine Natural products C1C=CCNC1C1=CC=CN=C1 SOPPBXUYQGUQHE-UHFFFAOYSA-N 0.000 claims abstract description 57
- 241000208125 Nicotiana Species 0.000 claims abstract description 41
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 39
- 229960002715 nicotine Drugs 0.000 claims abstract description 35
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims abstract description 32
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000002904 solvent Substances 0.000 claims abstract description 13
- 239000007788 liquid Substances 0.000 claims description 32
- MTXSIJUGVMTTMU-JTQLQIEISA-N (S)-anabasine Chemical compound N1CCCC[C@H]1C1=CC=CN=C1 MTXSIJUGVMTTMU-JTQLQIEISA-N 0.000 claims description 12
- MYKUKUCHPMASKF-VIFPVBQESA-N (S)-nornicotine Chemical compound C1CCN[C@@H]1C1=CC=CN=C1 MYKUKUCHPMASKF-VIFPVBQESA-N 0.000 claims description 12
- MYKUKUCHPMASKF-UHFFFAOYSA-N Nornicotine Natural products C1CCNC1C1=CC=CN=C1 MYKUKUCHPMASKF-UHFFFAOYSA-N 0.000 claims description 12
- 229930014345 anabasine Natural products 0.000 claims description 12
- 235000019505 tobacco product Nutrition 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- 239000007937 lozenge Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 3
- 239000007897 gelcap Substances 0.000 claims description 3
- 241001106067 Atropa Species 0.000 claims description 2
- 235000002566 Capsicum Nutrition 0.000 claims description 2
- 240000008574 Capsicum frutescens Species 0.000 claims description 2
- 241000208296 Datura Species 0.000 claims description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 2
- 240000007377 Petunia x hybrida Species 0.000 claims description 2
- 244000236480 Podophyllum peltatum Species 0.000 claims description 2
- 240000003768 Solanum lycopersicum Species 0.000 claims description 2
- 244000061458 Solanum melongena Species 0.000 claims description 2
- 235000002597 Solanum melongena Nutrition 0.000 claims description 2
- 244000061456 Solanum tuberosum Species 0.000 claims description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
- 239000001390 capsicum minimum Substances 0.000 claims description 2
- 235000015111 chews Nutrition 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 230000000391 smoking effect Effects 0.000 abstract description 11
- 235000019504 cigarettes Nutrition 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 6
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- 230000001988 toxicity Effects 0.000 abstract description 3
- 231100001261 hazardous Toxicity 0.000 abstract description 2
- 150000003839 salts Chemical class 0.000 description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 102000010909 Monoamine Oxidase Human genes 0.000 description 4
- 108010062431 Monoamine oxidase Proteins 0.000 description 4
- -1 steam Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 235000019788 craving Nutrition 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- 239000000779 smoke Substances 0.000 description 3
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- QCXJEYYXVJIFCE-UHFFFAOYSA-N 4-acetamidobenzoic acid Chemical compound CC(=O)NC1=CC=C(C(O)=O)C=C1 QCXJEYYXVJIFCE-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 238000002485 combustion reaction Methods 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- XTEGVFVZDVNBPF-UHFFFAOYSA-N naphthalene-1,5-disulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1S(O)(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N thiocyanic acid Chemical compound SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- SJJCQDRGABAVBB-UHFFFAOYSA-N 1-hydroxy-2-naphthoic acid Chemical compound C1=CC=CC2=C(O)C(C(=O)O)=CC=C21 SJJCQDRGABAVBB-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical class OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N 3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229960000250 adipic acid Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Chemical class OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- HABLENUWIZGESP-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O.CCCCCCCCCC(O)=O HABLENUWIZGESP-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- SXZIXHOMFPUIRK-UHFFFAOYSA-N diphenylmethanimine Chemical compound C=1C=CC=CC=1C(=N)C1=CC=CC=C1 SXZIXHOMFPUIRK-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008368 mint flavor Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000002287 radioligand Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 235000010215 titanium dioxide Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F15/00—Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor
- A24F15/01—Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor specially adapted for simulated smoking devices or cigarettes therefor
- A24F15/015—Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor specially adapted for simulated smoking devices or cigarettes therefor with means for refilling of liquid inhalable precursors
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/10—Devices using liquid inhalable precursors
Definitions
- e-cigarettes Electronic cigarettes (or “e-cigarettes”) have been developed as an alternative to traditional cigarettes as a means for volatizing active components, such as nicotine, for inhalation without combustion, while at the same time providing the user with an oral experience similar to that of traditional cigarette smoking
- U.S. Pat. No. 7,832,410 B2 to Hon describes an e-cigarette having a liquid supply bottle in communication with an atomizer for volatizing a nicotine-containing solution.
- U.S. Pat. No. 7,726,320 B2 to Robinson et al. discloses a smoking article having an electrically powered aerosol-generating device which heats tobacco contained within the device to generate an aerosol which is described as being similar to tobacco smoke.
- Embodiments of the present invention are directed to e-cigarettes, alkaloid compositions for e-cigarettes, and refilling cartridges for e-cigarettes containing certain alkaloid compositions.
- a refilling cartridge for an e-cigarette contains a liquid alkaloid composition comprising a solvent and at least about 25 wt. % anatabine based on the total alkaloid weight of the composition.
- a kit for refilling an e-cigarette comprises (i) a liquid alkaloid composition comprising a solvent and at least about 25 wt. % anatabine based on the total alkaloid weight of the composition, and (ii) instructions for filling the liquid alkaloid composition into a liquid receptacle of an e-cigarette.
- a method of refilling an e-cigarette includes the steps of (i) providing a liquid alkaloid composition comprising a solvent and at least about 25 wt. % anatabine based on the total alkaloid weight of the composition, and (ii) filling the liquid alkaloid composition into a liquid receptacle of an e-cigarette.
- an e-cigarette comprises a cartridge containing a liquid alkaloid composition comprising a solvent and at least about 25 wt. % anatabine based on the total alkaloid weight of the composition.
- the e-cigarette may be of a single-use or disposable type, or may be refillable with liquid alkaloid compositions to facilitate reuse.
- non-tobacco products that contain an alkaloid composition comprising about 25 wt. % to about 95 wt. % anatabine, and about 5 wt. % to about 75 wt. % of a second alkaloid, based on the total alkaloid weight of the composition.
- the second alkaloid may be nicotine, nornicotine, anabasine, or a combination of two or more of them.
- the non-tobacco product may be in the form of a solid bit of compressed powder, chewing gum, gelcap, capsule, pill, lozenge, or the like.
- the alkaloid compositions disclosed herein feature different ranges of alkaloids to provide an attractive alternative to smoking conventional e-cigarettes, in which nicotine makes up about 90 to 100 wt. % of the total alkaloid content.
- the disclosed alkaloid compositions are characterized by a significant quantity of anatabine, which has lower toxicity and risk of abuse as compared to other alkaloids such as nicotine.
- the alkaloid compositions enable individuals to experience the pleasure-enhancing attributes of conventional cigarette smoking, while avoiding exposure to combusted materials and other potentially hazardous components present in tobacco. As a result, individuals may be more likely to quit conventional cigarette smoking
- FIG. 1 is a schematic illustration of one example of an e-cigarette configuration.
- Tobacco is among the most chemically complex substances known, with tobacco and tobacco smoke containing more than 8,000 compounds.
- tobacco contains the minor alkaloids nornicotine, anabasine, and anatabine.
- nicotine is regarded as the principal addictive component in tobacco, a variety of other factors also are believed to contribute to tobacco addiction.
- tobacco smoke has been reported to have a monoamine oxidase (MAO) inhibitory effect.
- MAO is an enzyme involved in the breakdown of dopamine, a pleasure-enhancing neurotransmitter. See J. S. Fowler et al., “Inhibition of Monoamine Oxidase B in the Brain of Smokers,” Nature (Lond), 379(6567):733 736 (1996); J. Stephenson, “Clues Found to Tobacco Addiction,” Journal of the American Medical Association, 275(16): 1217-1218 (1996). See also Williams et al. U.S. Pat. No. 6,350,479.
- the alkaloid composition comprises at least about 25 wt. % anatabine based on the total alkaloid weight.
- anatabine is the sole alkaloid present in the composition, e.g., anatabine comprises 100 wt. % of the total alkaloid weight.
- up to about 75 wt. % of one or more other alkaloids, such as nicotine, nornicotine, and/or anabasine, may be present in addition to anatabine.
- anatabine and nicotine may be combined in a weight ratio (anatabine-to-nicotine) of about 50:1 to about 1:3, or from about 25:1 to about 1:2, from about 10:1 to about 3:2, or from about 5:1 to about 1:1.
- Anatabine may be prepared synthetically, such as via a benzophenoneimine pathway as described in co-pending application Ser. No. 12/729,346, filed Mar. 23, 2010, the disclosure of which is incorporated herein by reference in its entirety.
- Anatabine may be present in the form of a racemic mixture or as isolated enantiomer, e.g., R-(+)-anatabine or S-( ⁇ )-anatabine, and/or as one or more pharmaceutically acceptable (or food grade) salts of anatabine.
- anatabine refers to racemic mixtures of anatabine, enantiomers of anatabine, salt and non-salt forms of anatabine, as well as salt and non-salt forms of anatabine enantiomers.
- salts are described in P. H.
- anatabine may be obtained by extraction from tobacco or other plants, such as members of the Solanaceae family, such as datura, mandrake, belladonna, capsicum, potato, tomato, nicotiana, eggplant, and petunia.
- a tobacco extract may be prepared from cured tobacco stems, lamina, or both. Flue (bright) varieties of tobacco are often used, i.e., Virginia flue. Other tobacco varieties may be used, such as Burley, dark-fired, and/or other commercial tobacco varieties. Two or more tobacco varieties may be combined to form a blend.
- cured tobacco material is extracted with a solvent, typically water, ethanol, steam, or carbon dioxide.
- the resulting solution contains the soluble components of the tobacco, including alkaloids such as anatabine.
- Anatabine may be purified using known techniques such as liquid chromatography.
- the amount of anatabine present in the composition may vary depending on factors such as the type of e-cigarette and whether other active components, such as nicotine and/or other alkaloids, are present.
- the amount of anatabine may range from about 0.1 to about 25 mg, from about 0.5 to about 20 mg, or from about 1 to about 10 mg, per total gram of composition.
- compositions containing anatabine were found to be efficacious for the temporary reduction of tobacco cravings, even without the presence of nicotine.
- Anatabine and other minor alkaloids also have been reported to bind to nicotinic receptors. See “Receptors for Nicotine in the Central Nervous System: 1 Radioligand Binding Studies,” Group Research & Development Centre, British-American Tobacco Co. Ltd. (1984).
- the composition may contain up to about 75 wt. % of one or more other alkaloids, such as nicotine, nornicotine, and/or anabasine, based on the total alkaloid weight.
- alkaloids may be extracted from tobacco or other plant materials and purified using known techniques, and/or prepared synthetically using known synthesis methods.
- Anatabine and additional alkaloid(s), such as nicotine may be combined in a weight ratio (anatabine-to-total other alkaloids) of about 50:1 to about 1:3, or from about 25:1 to about 1:2, from about 10:1 to about 3:2, or from about 5:1 to about 1:1.
- the composition typically contains other components such as water, organic solvents, sweetening and/or flavoring agents, and the like.
- solvents that are commonly used in liquid compositions for e-cigarettes include polyhydric alcohols such as 1,2-propylene glycol (PG or MPG); monohydric alcohols such as ethanol; ethyl acetate; and the like.
- the amount of water present typically ranges from about 0.1 to about 10 wt. %, usually from about 0.5 to about 5 wt. %.
- the amount of organic solvent present typically ranges from about 50 to about 99 wt. %, often from about 75 to about 95 wt. %.
- one or more flavorants may be added to the composition, non-limiting examples of which include peppermint, menthol, wintergreen, spearmint, propolis, eucalyptus, cinnamon, or the like.
- the total amount of flavorants typically ranges from about 0.5 to about 15 wt. %, often from about 1 to about 10 wt. %, based on the total weight of the composition.
- the e-cigarette may be of various types of configurations, the details of which form no part of the present invention.
- e-cigarettes may be of a single-use or disposable type, or may be refillable with liquid alkaloid compositions and/or cartridges containing liquid compositions to facilitate reuse.
- FIG. 1 An air inlet 4 is provided on the external wall of a shell 14 which houses LED 1 , cell 2 , electronic circuit board 3 , normal pressure cavity 5 , sensor 6 , vapor-liquid separator 7 , atomizer 9 , liquid-supplying bottle 11 , mouthpiece 15 , microswitch 16 , gas vent 17 , and air passage 18 .
- the electronic circuit board 3 has an electronic switching circuit and a high frequency generator.
- a negative pressure cavity 8 is provided in the sensor 6 and is separated from the sensor 6 by a ripple film.
- An atomization cavity 10 is provided in the atomizer 9 .
- a retaining ring 13 is provided for locking the liquid-supplying bottle 11 between one side of the liquid-supplying bottle 11 and the shell 14 ; and an aerosol passage 12 is provided on the other side of the liquid-supplying bottle.
- e-cigarettes that reduce cravings for traditional tobacco smoking, while minimizing toxicity and other undesirable side effects associated with nicotine and other tobacco components.
- the e-cigarette may be used as needed to satisfy cravings, or at intervals such as once daily, twice daily, or three or more times daily, depending on such factors as the concentration of active components and the subject's physiological conditions.
- a non-tobacco formulation contains an alkaloid composition comprising about 25 wt. % to about 95 wt. % anatabine, and about 5 wt. % to about 75 wt. % of a second alkaloid, based on the total alkaloid weight of the composition.
- the second alkaloid may be nicotine, nornicotine, anabasine, or a combination of two or more of them.
- the non-tobacco product may be in the form of a solid bit of compressed powder, chewing gum, capsule, pill, lozenge, or the like.
- non-tobacco means that the product is essentially free of tobacco leaf or tobacco extract, except however that some or all of the alkaloids present in the non-tobacco product may be extracted from tobacco and purified using conventional techniques such as liquid chromatography.
- Additional components ingredients may be added to the non-tobacco products to improve taste or stability.
- additional components include, but are not limited to, sweeteners, natural flavorants, artificial flavorants, colorants, antioxidants, preservatives, chelating agents, viscomodulators, tonicifiers, odorants, opacifiers, suspending agents, binders, thickeners, and mixtures thereof, including, but not limited to, xanthum gum, carboxymethylcellulose, carboxyethylcellulose, hydroxypropylcellulose, methylcellulose, microcrystalline cellulose, starches, dextrins, fermented whey, tofu, maltodextrins, polyols (including sugar alcohols, such as sorbitol or mannitol), carbohydrates (e.g., lactose), propylene hlycol alginate, gellan gum, guar, pectin, tragacanth gum, gum acacia, locust bean gum, gum arabic, gelatin,
- the non-tobacco products may be in a variety of forms, e.g., to be taken orally, such as pills, tablets, capsules, soft gels, gelcaps, liquids, syrups, suspensions, powders, chews, lozenges, gum, bars, etc., or to be administered by other routes, such as parenterally, by inhalation spray, topically, via an implanted reservoir, etc.
- the alkaloid compositions also can be prepared to be administered in foods or beverages. For example, they can be supplied as a dried or powdered product for reconstitution with water or other suitable vehicle before use (e.g., milk, fruit juice, and the like).
- Alkaloid compositions for e-cigarettes may be prepared by combining the components listed in Table 1 below and mixing to form a solution.
- Anatabine may be prepared synthetically as described in Examples 1-3 of co-pending application Ser. No. 12/729,346. Nicotine, anabasine, and nornicotine may be extracted from tobacco materials and purified using known techniques.
- compositions described in Examples 1-8 may be filled into refilling cartridges for e-cigarettes, or filled into a liquid container that is used as part of a kit for refilling liquid receptacles in e-cigarettes.
- the compositions alternatively may be filled into a single-use or disposable type of e-cigarette.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Manufacture Of Tobacco Products (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/493,132 US20120325228A1 (en) | 2011-06-23 | 2012-06-11 | Alkaloid composition for e-cigarette |
| US13/946,201 US20130298921A1 (en) | 2011-06-23 | 2013-07-19 | Inhaler for smoking cessation |
| US14/672,716 US20160050968A1 (en) | 2011-06-23 | 2015-03-30 | Alkaloid Composition for E-Cigarette |
| US15/679,731 US20180184704A1 (en) | 2011-06-23 | 2017-08-17 | Alkaloid Composition for E-Cigarette |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161500237P | 2011-06-23 | 2011-06-23 | |
| US13/493,132 US20120325228A1 (en) | 2011-06-23 | 2012-06-11 | Alkaloid composition for e-cigarette |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/946,201 Continuation-In-Part US20130298921A1 (en) | 2011-06-23 | 2013-07-19 | Inhaler for smoking cessation |
| US14/672,716 Continuation US20160050968A1 (en) | 2011-06-23 | 2015-03-30 | Alkaloid Composition for E-Cigarette |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20120325228A1 true US20120325228A1 (en) | 2012-12-27 |
Family
ID=47360634
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/493,132 Abandoned US20120325228A1 (en) | 2011-06-23 | 2012-06-11 | Alkaloid composition for e-cigarette |
| US14/672,716 Abandoned US20160050968A1 (en) | 2011-06-23 | 2015-03-30 | Alkaloid Composition for E-Cigarette |
| US15/679,731 Abandoned US20180184704A1 (en) | 2011-06-23 | 2017-08-17 | Alkaloid Composition for E-Cigarette |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/672,716 Abandoned US20160050968A1 (en) | 2011-06-23 | 2015-03-30 | Alkaloid Composition for E-Cigarette |
| US15/679,731 Abandoned US20180184704A1 (en) | 2011-06-23 | 2017-08-17 | Alkaloid Composition for E-Cigarette |
Country Status (2)
| Country | Link |
|---|---|
| US (3) | US20120325228A1 (fr) |
| WO (1) | WO2012177510A2 (fr) |
Cited By (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103876273A (zh) * | 2014-03-12 | 2014-06-25 | 红塔烟草(集团)有限责任公司 | 一种混合型电子卷烟烟液及制备方法 |
| CN103932382A (zh) * | 2014-03-12 | 2014-07-23 | 红塔烟草(集团)有限责任公司 | 一种清香型电子卷烟烟液及制备方法 |
| WO2014150881A1 (fr) * | 2013-03-15 | 2014-09-25 | Dongmei Xu | Produits contenant de la nicotine et de l'anatabine et leurs procédés de fabrication |
| CN104087414A (zh) * | 2014-07-28 | 2014-10-08 | 嘉兴市得百科新材料科技有限公司 | 一种蓝莓风味的电子烟液及其制备方法 |
| CN104172463A (zh) * | 2014-08-07 | 2014-12-03 | 江苏中烟工业有限责任公司 | 一种电子烟烟液溶剂及电子烟烟液 |
| ITBO20130504A1 (it) * | 2013-09-18 | 2015-03-19 | Gd Spa | Metodo ed unita' di riempimento di una cartuccia monouso per sigarette elettroniche con una sostanza liquida. |
| US20150083146A1 (en) * | 2013-09-23 | 2015-03-26 | Verso PV, LLC | Personal vaporizer liquid for emulsifying oil-soluble compounds and resins |
| US20150128966A1 (en) * | 2012-05-14 | 2015-05-14 | Nicoventures Holdings Limited | Electronic vapor provision device |
| US9095175B2 (en) | 2010-05-15 | 2015-08-04 | R. J. Reynolds Tobacco Company | Data logging personal vaporizing inhaler |
| WO2015117243A1 (fr) * | 2014-02-07 | 2015-08-13 | Bellerose Samuel | Composition liquide pour e-cigarettes |
| WO2015149330A1 (fr) * | 2014-04-03 | 2015-10-08 | 吉瑞高新科技股份有限公司 | Cigarette électronique |
| WO2015157928A1 (fr) * | 2014-04-16 | 2015-10-22 | 吉瑞高新科技股份有限公司 | Cigarette électronique |
| CN105124763A (zh) * | 2015-09-06 | 2015-12-09 | 叶菁 | 非燃烧型低温卷烟用相变控温式燃料组件及其制备方法 |
| US9259035B2 (en) | 2010-05-15 | 2016-02-16 | R. J. Reynolds Tobacco Company | Solderless personal vaporizing inhaler |
| CN105559148A (zh) * | 2016-02-27 | 2016-05-11 | 卓尔悦(常州)电子科技有限公司 | 雾化器及其电子烟 |
| US9352288B2 (en) | 2010-05-15 | 2016-05-31 | Rai Strategic Holdings, Inc. | Vaporizer assembly and cartridge |
| WO2016133890A1 (fr) * | 2015-02-19 | 2016-08-25 | Srq Patent Holdings, Llc | Compositions pour cigarettes électroniques |
| CN106072767A (zh) * | 2016-06-28 | 2016-11-09 | 卓尔悦欧洲控股有限公司 | 雾化头、雾化器及其电子烟 |
| US9743691B2 (en) | 2010-05-15 | 2017-08-29 | Rai Strategic Holdings, Inc. | Vaporizer configuration, control, and reporting |
| WO2017210968A1 (fr) * | 2016-06-08 | 2017-12-14 | 卓尔悦(常州)电子科技有限公司 | Cigarette électronique |
| WO2018073261A1 (fr) * | 2016-10-18 | 2018-04-26 | Philip Morris Products S.A. | Procédés et systèmes destinés à améliorer la stabilité de la formulation de pré-vapeur d'un dispositif de vapotage électronique |
| US9999250B2 (en) | 2010-05-15 | 2018-06-19 | Rai Strategic Holdings, Inc. | Vaporizer related systems, methods, and apparatus |
| US10034988B2 (en) | 2012-11-28 | 2018-07-31 | Fontem Holdings I B.V. | Methods and devices for compound delivery |
| USD825102S1 (en) | 2016-07-28 | 2018-08-07 | Juul Labs, Inc. | Vaporizer device with cartridge |
| US10045567B2 (en) | 2013-12-23 | 2018-08-14 | Juul Labs, Inc. | Vaporization device systems and methods |
| US10045568B2 (en) | 2013-12-23 | 2018-08-14 | Juul Labs, Inc. | Vaporization device systems and methods |
| US10058130B2 (en) | 2013-12-23 | 2018-08-28 | Juul Labs, Inc. | Cartridge for use with a vaporizer device |
| US10076139B2 (en) | 2013-12-23 | 2018-09-18 | Juul Labs, Inc. | Vaporizer apparatus |
| WO2018176676A1 (fr) * | 2017-03-31 | 2018-10-04 | 纳智源科技(唐山)有限责任公司 | Dispositif et système de surveillance de quantité de fumée de tabac |
| US10092713B2 (en) | 2010-05-15 | 2018-10-09 | Rai Strategic Holdings, Inc. | Personal vaporizing inhaler with translucent window |
| US10104915B2 (en) | 2013-12-23 | 2018-10-23 | Juul Labs, Inc. | Securely attaching cartridges for vaporizer devices |
| US10111470B2 (en) | 2013-12-23 | 2018-10-30 | Juul Labs, Inc. | Vaporizer apparatus |
| US10136672B2 (en) | 2010-05-15 | 2018-11-27 | Rai Strategic Holdings, Inc. | Solderless directly written heating elements |
| USD836541S1 (en) | 2016-06-23 | 2018-12-25 | Pax Labs, Inc. | Charging device |
| US10159278B2 (en) | 2010-05-15 | 2018-12-25 | Rai Strategic Holdings, Inc. | Assembly directed airflow |
| US10194693B2 (en) | 2013-09-20 | 2019-02-05 | Fontem Holdings 1 B.V. | Aerosol generating device |
| USD842536S1 (en) | 2016-07-28 | 2019-03-05 | Juul Labs, Inc. | Vaporizer cartridge |
| US10244793B2 (en) | 2005-07-19 | 2019-04-02 | Juul Labs, Inc. | Devices for vaporization of a substance |
| US10251422B2 (en) | 2013-07-22 | 2019-04-09 | Altria Client Services Llc | Electronic smoking article |
| US10279934B2 (en) | 2013-03-15 | 2019-05-07 | Juul Labs, Inc. | Fillable vaporizer cartridge and method of filling |
| USD848057S1 (en) | 2016-06-23 | 2019-05-07 | Pax Labs, Inc. | Lid for a vaporizer |
| USD849996S1 (en) | 2016-06-16 | 2019-05-28 | Pax Labs, Inc. | Vaporizer cartridge |
| KR20190062396A (ko) * | 2016-10-18 | 2019-06-05 | 필립모리스 프로덕츠 에스.에이. | E-베이핑 장치의 기화전 제제의 안정성을 증가시키기 위한 방법 및 시스템 |
| USD851830S1 (en) | 2016-06-23 | 2019-06-18 | Pax Labs, Inc. | Combined vaporizer tamp and pick tool |
| US10334887B1 (en) | 2016-06-08 | 2019-07-02 | Joyetech Europe Holding Gmbh | Atomizer and electronic cigarette |
| US10405582B2 (en) | 2016-03-10 | 2019-09-10 | Pax Labs, Inc. | Vaporization device with lip sensing |
| US10471052B2 (en) | 2015-02-19 | 2019-11-12 | Mymd Pharmaceuticals, Inc. | Method of treating addictions to opioids |
| US10512282B2 (en) | 2014-12-05 | 2019-12-24 | Juul Labs, Inc. | Calibrated dose control |
| USD887632S1 (en) | 2017-09-14 | 2020-06-16 | Pax Labs, Inc. | Vaporizer cartridge |
| FR3089761A1 (fr) * | 2018-12-12 | 2020-06-19 | E-Rag | Composition liquide de cigarette électronique |
| US10865001B2 (en) | 2016-02-11 | 2020-12-15 | Juul Labs, Inc. | Fillable vaporizer cartridge and method of filling |
| US10874139B2 (en) | 2015-07-07 | 2020-12-29 | Altria Client Services Llc | E-vapor device including capsule containing pre-vapor formulation |
| US20210007397A1 (en) * | 2016-05-31 | 2021-01-14 | Altria Client Services Llc | Refillable aerosol-generating article |
| CN113163845A (zh) * | 2018-12-31 | 2021-07-23 | 菲利普莫里斯生产公司 | 包含部分水溶性溶剂的液体尼古丁制剂 |
| CN113208148A (zh) * | 2021-05-12 | 2021-08-06 | 云南中烟工业有限责任公司 | 一种协同释放尼古丁和致香成分的超分子凝胶 |
| GB2595967A (en) * | 2020-05-01 | 2021-12-15 | Exhale Tech Ltd | Composition and use thereof |
| US20220273019A1 (en) * | 2018-11-01 | 2022-09-01 | Nicoventures Trading Limited | Gel and crystalline powder |
| CN115166070A (zh) * | 2022-06-16 | 2022-10-11 | 深圳萨特瓦生物科技有限公司 | 烟油或气溶胶中烟碱含量的测试方法及配制电子烟烟油的方法 |
| IT202100027086A1 (it) * | 2021-10-21 | 2023-04-21 | Alberto Patarchi | Erogatore portatile per il trattamento o la prevenzione di un’infezione o di una patologia causata da un virus |
| US20230157347A1 (en) * | 2013-12-05 | 2023-05-25 | Juul Labs, Inc. | Nicotine liquid formulations for aerosol devices and methods thereof |
| JP2023157820A (ja) * | 2022-04-15 | 2023-10-26 | 汪冶 | 霧化電子送達製品に用いられる霧化溶液 |
| JP2023158617A (ja) * | 2022-04-18 | 2023-10-30 | 汪冶 | 加熱式非燃焼電子送達製品におけるアナバシンの使用、固体フレーク及びその製造方法 |
| US11819608B2 (en) | 2017-12-22 | 2023-11-21 | Nicoventures Trading Limited | Electronic aerosol provision system |
| USD1028336S1 (en) | 2021-06-22 | 2024-05-21 | Pax Labs, Inc. | Vaporizer cartridge |
| US12133952B2 (en) | 2010-05-15 | 2024-11-05 | Rai Strategic Holdings, Inc. | Vaporizer related systems, methods, and apparatus |
| US12156533B2 (en) | 2013-05-06 | 2024-12-03 | Juul Labs, Inc. | Nicotine salt formulations for aerosol devices and methods thereof |
| US12279647B2 (en) | 2019-12-23 | 2025-04-22 | Pax Labs, Inc. | Vaporizer cartridge |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104082853B (zh) * | 2014-07-07 | 2015-10-21 | 嘉兴市得百科新材料科技有限公司 | 一种含番茄提取物的电子烟液及其制备方法 |
| CN104397871B (zh) * | 2014-09-15 | 2016-05-04 | 云南中烟工业有限责任公司 | 一种含茶叶提取物的电子烟烟油及其制备方法 |
| CN104287085B (zh) * | 2014-10-10 | 2017-01-25 | 安徽中烟工业有限责任公司 | 一种具有防漏液功能的电子烟烟液 |
| CN104489901B (zh) * | 2014-12-03 | 2016-06-29 | 河南中烟工业有限责任公司 | 一种烟草口味电子烟烟液 |
| EP3313173A1 (fr) | 2015-06-26 | 2018-05-02 | Altria Client Services LLC | Compositions et procédés de production de plants de tabac et produits à niveaux d'alcaloïdes modifiés |
| CN105029681B (zh) * | 2015-07-14 | 2017-10-31 | 中国烟草总公司郑州烟草研究院 | 适用于电子烟烟液的天然香料精制液、烟液及其制备方法 |
| CN108077992B (zh) * | 2017-12-18 | 2019-01-18 | 山东精彩香料科技开发有限公司 | 一种加热不燃烧卷烟用抽吸颗粒及制造方法 |
| US20200035118A1 (en) | 2018-07-27 | 2020-01-30 | Joseph Pandolfino | Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes |
| US10897925B2 (en) | 2018-07-27 | 2021-01-26 | Joseph Pandolfino | Articles and formulations for smoking products and vaporizers |
| CN108968138B (zh) * | 2018-10-09 | 2021-02-02 | 湖北中烟工业有限责任公司 | 用于改善加热不燃烧烟草烟气状态的香精及其制备方法和应用 |
| JP2022514283A (ja) | 2018-12-17 | 2022-02-10 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | 3-(1,2,3,6-テトラヒドロピリジン-2-イル)ピリジングルタレートまたはその薬学的に許容可能な溶媒和化合物 |
| CN118984653A (zh) | 2023-01-18 | 2024-11-19 | 瑞迪美天然有限公司 | 可蒸发生物碱组合物及其使用方法 |
| US20240245092A1 (en) | 2023-01-18 | 2024-07-25 | Ready Mix Naturals, LLC | Vaporizable alkaloid compositions and methods of use thereof |
| WO2025096261A1 (fr) * | 2023-10-31 | 2025-05-08 | Ready Mix Naturals, LLC | Compositions alcaloïdes vaporisables et leurs procédés d'utilisation |
Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6041789A (en) * | 1999-01-28 | 2000-03-28 | K&B Technologies, L.L.C. | Cigarette substitute device and composition for use therein |
| US20020054926A1 (en) * | 1998-06-05 | 2002-05-09 | Regent Court Technologies | Monoamine oxidase (MAO) inhibitors and uses thereof |
| US20040013752A1 (en) * | 2002-07-05 | 2004-01-22 | Wolfson Philip E. | Buccal and sublingual mucosally absorbed herbal compositions for relieving nicotine withdrawal symptoms and craving for nicotine and nicotine containing substances |
| US20050172976A1 (en) * | 2002-10-31 | 2005-08-11 | Newman Deborah J. | Electrically heated cigarette including controlled-release flavoring |
| US20050260420A1 (en) * | 2003-04-01 | 2005-11-24 | Collins Martha J | Low dielectric materials and methods for making same |
| US20070267031A1 (en) * | 2004-04-14 | 2007-11-22 | Lik Hon | Electronic Atomization Cigarette |
| US20080156336A1 (en) * | 2006-08-25 | 2008-07-03 | Philip Morris Usa Inc. | Smoking article with encapsulated flavourant |
| US20080257367A1 (en) * | 2007-04-23 | 2008-10-23 | Greg Paterno | Electronic evaporable substance delivery device and method |
| US20090126745A1 (en) * | 2006-05-16 | 2009-05-21 | Lik Hon | Emulation Aerosol Sucker |
| WO2009105919A1 (fr) * | 2008-02-29 | 2009-09-03 | Xiu Yunqiang | Simulateur électronique de cigarette et son liquide d'atomisation, dispositif à fumer pour simulateur électronique de cigarette et sa capsule de liquide à fumer |
| US20090272379A1 (en) * | 2008-04-30 | 2009-11-05 | Philip Morris Usa Inc. | Electrically heated smoking system having a liquid storage portion |
| US20100236562A1 (en) * | 2007-06-25 | 2010-09-23 | Alex Hearn | Inhalable composition |
| US20110265806A1 (en) * | 2010-04-30 | 2011-11-03 | Ramon Alarcon | Electronic smoking device |
| US20120186594A1 (en) * | 2009-09-18 | 2012-07-26 | Minilogic Device Corporation Ltd. | Electronic smoke |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6534527B2 (en) * | 2000-06-02 | 2003-03-18 | Phytos, Inc. | Edible herbal compositions for relieving nicotine craving |
| US7458374B2 (en) * | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| US6552035B2 (en) * | 2001-09-13 | 2003-04-22 | Hwa-Mok Park | Composition for inducing smoking cessation comprising alkaloids from Radix ipecauanhae |
| US20100160376A1 (en) * | 2001-12-10 | 2010-06-24 | Marshall Anlauf Thompson | Nicotine-alternative compositions and methods of producing such compositions |
-
2012
- 2012-06-11 US US13/493,132 patent/US20120325228A1/en not_active Abandoned
- 2012-06-15 WO PCT/US2012/042710 patent/WO2012177510A2/fr not_active Ceased
-
2015
- 2015-03-30 US US14/672,716 patent/US20160050968A1/en not_active Abandoned
-
2017
- 2017-08-17 US US15/679,731 patent/US20180184704A1/en not_active Abandoned
Patent Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020054926A1 (en) * | 1998-06-05 | 2002-05-09 | Regent Court Technologies | Monoamine oxidase (MAO) inhibitors and uses thereof |
| US6041789A (en) * | 1999-01-28 | 2000-03-28 | K&B Technologies, L.L.C. | Cigarette substitute device and composition for use therein |
| US20040013752A1 (en) * | 2002-07-05 | 2004-01-22 | Wolfson Philip E. | Buccal and sublingual mucosally absorbed herbal compositions for relieving nicotine withdrawal symptoms and craving for nicotine and nicotine containing substances |
| US20050172976A1 (en) * | 2002-10-31 | 2005-08-11 | Newman Deborah J. | Electrically heated cigarette including controlled-release flavoring |
| US20050260420A1 (en) * | 2003-04-01 | 2005-11-24 | Collins Martha J | Low dielectric materials and methods for making same |
| US20070267031A1 (en) * | 2004-04-14 | 2007-11-22 | Lik Hon | Electronic Atomization Cigarette |
| US20090126745A1 (en) * | 2006-05-16 | 2009-05-21 | Lik Hon | Emulation Aerosol Sucker |
| US20080156336A1 (en) * | 2006-08-25 | 2008-07-03 | Philip Morris Usa Inc. | Smoking article with encapsulated flavourant |
| US20080257367A1 (en) * | 2007-04-23 | 2008-10-23 | Greg Paterno | Electronic evaporable substance delivery device and method |
| US20100236562A1 (en) * | 2007-06-25 | 2010-09-23 | Alex Hearn | Inhalable composition |
| WO2009105919A1 (fr) * | 2008-02-29 | 2009-09-03 | Xiu Yunqiang | Simulateur électronique de cigarette et son liquide d'atomisation, dispositif à fumer pour simulateur électronique de cigarette et sa capsule de liquide à fumer |
| US20110005535A1 (en) * | 2008-02-29 | 2011-01-13 | Yunqiang Xiu | Electronic simulated cigarette and atomizing liquid thereof, smoking set for electronic simulated cigarette and smoking liquid capsule thereof |
| US20090272379A1 (en) * | 2008-04-30 | 2009-11-05 | Philip Morris Usa Inc. | Electrically heated smoking system having a liquid storage portion |
| US20120186594A1 (en) * | 2009-09-18 | 2012-07-26 | Minilogic Device Corporation Ltd. | Electronic smoke |
| US20110265806A1 (en) * | 2010-04-30 | 2011-11-03 | Ramon Alarcon | Electronic smoking device |
Cited By (115)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10244793B2 (en) | 2005-07-19 | 2019-04-02 | Juul Labs, Inc. | Devices for vaporization of a substance |
| US12133952B2 (en) | 2010-05-15 | 2024-11-05 | Rai Strategic Holdings, Inc. | Vaporizer related systems, methods, and apparatus |
| US9861773B2 (en) | 2010-05-15 | 2018-01-09 | Rai Strategic Holdings, Inc. | Communication between personal vaporizing inhaler assemblies |
| US12246129B2 (en) | 2010-05-15 | 2025-03-11 | Rai Strategic Holdings, Inc. | Vaporizing unit with use authorization |
| US12246128B2 (en) | 2010-05-15 | 2025-03-11 | Rai Strategic Holdings, Inc. | Vaporizer related systems, methods, and apparatus |
| US12233202B2 (en) | 2010-05-15 | 2025-02-25 | Rai Strategic Holdings, Inc. | Vaporizing unit with dry wick indication |
| US9743691B2 (en) | 2010-05-15 | 2017-08-29 | Rai Strategic Holdings, Inc. | Vaporizer configuration, control, and reporting |
| US12138384B1 (en) | 2010-05-15 | 2024-11-12 | Rai Strategic Holdings, Inc. | Vaporizer related systems, methods, and apparatus |
| US9555203B2 (en) | 2010-05-15 | 2017-01-31 | Rai Strategic Holdings, Inc. | Personal vaporizing inhaler assembly |
| US9095175B2 (en) | 2010-05-15 | 2015-08-04 | R. J. Reynolds Tobacco Company | Data logging personal vaporizing inhaler |
| US9999250B2 (en) | 2010-05-15 | 2018-06-19 | Rai Strategic Holdings, Inc. | Vaporizer related systems, methods, and apparatus |
| US9861772B2 (en) | 2010-05-15 | 2018-01-09 | Rai Strategic Holdings, Inc. | Personal vaporizing inhaler cartridge |
| US12324880B2 (en) | 2010-05-15 | 2025-06-10 | Rai Strategic Holdings, Inc. | Vaporizer cartridge and airflow path therethrough |
| US9427711B2 (en) | 2010-05-15 | 2016-08-30 | Rai Strategic Holdings, Inc. | Distal end inserted personal vaporizing inhaler cartridge |
| US9259035B2 (en) | 2010-05-15 | 2016-02-16 | R. J. Reynolds Tobacco Company | Solderless personal vaporizing inhaler |
| US10159278B2 (en) | 2010-05-15 | 2018-12-25 | Rai Strategic Holdings, Inc. | Assembly directed airflow |
| US9352288B2 (en) | 2010-05-15 | 2016-05-31 | Rai Strategic Holdings, Inc. | Vaporizer assembly and cartridge |
| US10136672B2 (en) | 2010-05-15 | 2018-11-27 | Rai Strategic Holdings, Inc. | Solderless directly written heating elements |
| US10092713B2 (en) | 2010-05-15 | 2018-10-09 | Rai Strategic Holdings, Inc. | Personal vaporizing inhaler with translucent window |
| US9955724B2 (en) * | 2012-05-14 | 2018-05-01 | Nicoventures Holdings Limited | Electronic vapor provision device |
| US20150128966A1 (en) * | 2012-05-14 | 2015-05-14 | Nicoventures Holdings Limited | Electronic vapor provision device |
| US10034988B2 (en) | 2012-11-28 | 2018-07-31 | Fontem Holdings I B.V. | Methods and devices for compound delivery |
| US10279934B2 (en) | 2013-03-15 | 2019-05-07 | Juul Labs, Inc. | Fillable vaporizer cartridge and method of filling |
| US10638792B2 (en) | 2013-03-15 | 2020-05-05 | Juul Labs, Inc. | Securely attaching cartridges for vaporizer devices |
| WO2014150881A1 (fr) * | 2013-03-15 | 2014-09-25 | Dongmei Xu | Produits contenant de la nicotine et de l'anatabine et leurs procédés de fabrication |
| US12156533B2 (en) | 2013-05-06 | 2024-12-03 | Juul Labs, Inc. | Nicotine salt formulations for aerosol devices and methods thereof |
| US10251422B2 (en) | 2013-07-22 | 2019-04-09 | Altria Client Services Llc | Electronic smoking article |
| CN105658523A (zh) * | 2013-09-18 | 2016-06-08 | 吉第联合股份公司 | 为一次性电子烟烟盒填装液体物质的方法和单元 |
| ITBO20130504A1 (it) * | 2013-09-18 | 2015-03-19 | Gd Spa | Metodo ed unita' di riempimento di una cartuccia monouso per sigarette elettroniche con una sostanza liquida. |
| US9668520B2 (en) | 2013-09-18 | 2017-06-06 | G.D Societa' Per Azioni | Method and unit for filling a disposable electronic-cigarette cartridge with a liquid substance |
| WO2015040568A1 (fr) * | 2013-09-18 | 2015-03-26 | G.D Societa' Per Azioni | Procédé et unité pour remplissage d'une cartouche de cigarette électronique jetable avec une substance liquide |
| US10194693B2 (en) | 2013-09-20 | 2019-02-05 | Fontem Holdings 1 B.V. | Aerosol generating device |
| US20150083146A1 (en) * | 2013-09-23 | 2015-03-26 | Verso PV, LLC | Personal vaporizer liquid for emulsifying oil-soluble compounds and resins |
| US12167744B2 (en) | 2013-12-05 | 2024-12-17 | Juul Labs, Inc. | Nicotine liquid formulations for aerosol devices and methods thereof |
| US20230157347A1 (en) * | 2013-12-05 | 2023-05-25 | Juul Labs, Inc. | Nicotine liquid formulations for aerosol devices and methods thereof |
| US11744277B2 (en) * | 2013-12-05 | 2023-09-05 | Juul Labs, Inc. | Nicotine liquid formulations for aerosol devices and methods thereof |
| US10045567B2 (en) | 2013-12-23 | 2018-08-14 | Juul Labs, Inc. | Vaporization device systems and methods |
| US10058129B2 (en) | 2013-12-23 | 2018-08-28 | Juul Labs, Inc. | Vaporization device systems and methods |
| US10058130B2 (en) | 2013-12-23 | 2018-08-28 | Juul Labs, Inc. | Cartridge for use with a vaporizer device |
| US10070669B2 (en) | 2013-12-23 | 2018-09-11 | Juul Labs, Inc. | Cartridge for use with a vaporizer device |
| US10076139B2 (en) | 2013-12-23 | 2018-09-18 | Juul Labs, Inc. | Vaporizer apparatus |
| US10264823B2 (en) | 2013-12-23 | 2019-04-23 | Juul Labs, Inc. | Vaporization device systems and methods |
| US11752283B2 (en) | 2013-12-23 | 2023-09-12 | Juul Labs, Inc. | Vaporization device systems and methods |
| US10104915B2 (en) | 2013-12-23 | 2018-10-23 | Juul Labs, Inc. | Securely attaching cartridges for vaporizer devices |
| US10111470B2 (en) | 2013-12-23 | 2018-10-30 | Juul Labs, Inc. | Vaporizer apparatus |
| US10117466B2 (en) | 2013-12-23 | 2018-11-06 | Juul Labs, Inc. | Vaporization device systems and methods |
| US10117465B2 (en) | 2013-12-23 | 2018-11-06 | Juul Labs, Inc. | Vaporization device systems and methods |
| US10058124B2 (en) | 2013-12-23 | 2018-08-28 | Juul Labs, Inc. | Vaporization device systems and methods |
| US10045568B2 (en) | 2013-12-23 | 2018-08-14 | Juul Labs, Inc. | Vaporization device systems and methods |
| US10159282B2 (en) | 2013-12-23 | 2018-12-25 | Juul Labs, Inc. | Cartridge for use with a vaporizer device |
| US10667560B2 (en) | 2013-12-23 | 2020-06-02 | Juul Labs, Inc. | Vaporizer apparatus |
| US10701975B2 (en) | 2013-12-23 | 2020-07-07 | Juul Labs, Inc. | Vaporization device systems and methods |
| US10201190B2 (en) | 2013-12-23 | 2019-02-12 | Juul Labs, Inc. | Cartridge for use with a vaporizer device |
| US10912331B2 (en) | 2013-12-23 | 2021-02-09 | Juul Labs, Inc. | Vaporization device systems and methods |
| WO2015117243A1 (fr) * | 2014-02-07 | 2015-08-13 | Bellerose Samuel | Composition liquide pour e-cigarettes |
| CN103932382A (zh) * | 2014-03-12 | 2014-07-23 | 红塔烟草(集团)有限责任公司 | 一种清香型电子卷烟烟液及制备方法 |
| CN103876273A (zh) * | 2014-03-12 | 2014-06-25 | 红塔烟草(集团)有限责任公司 | 一种混合型电子卷烟烟液及制备方法 |
| WO2015149330A1 (fr) * | 2014-04-03 | 2015-10-08 | 吉瑞高新科技股份有限公司 | Cigarette électronique |
| CN106413441A (zh) * | 2014-04-03 | 2017-02-15 | 吉瑞高新科技股份有限公司 | 电子烟 |
| WO2015157928A1 (fr) * | 2014-04-16 | 2015-10-22 | 吉瑞高新科技股份有限公司 | Cigarette électronique |
| CN104087414A (zh) * | 2014-07-28 | 2014-10-08 | 嘉兴市得百科新材料科技有限公司 | 一种蓝莓风味的电子烟液及其制备方法 |
| CN104172463A (zh) * | 2014-08-07 | 2014-12-03 | 江苏中烟工业有限责任公司 | 一种电子烟烟液溶剂及电子烟烟液 |
| US10512282B2 (en) | 2014-12-05 | 2019-12-24 | Juul Labs, Inc. | Calibrated dose control |
| WO2016133890A1 (fr) * | 2015-02-19 | 2016-08-25 | Srq Patent Holdings, Llc | Compositions pour cigarettes électroniques |
| US11331310B2 (en) | 2015-02-19 | 2022-05-17 | MyMD Pharmaceuticals (Florida), Inc. | Method of treating cocaine addiction |
| US10471052B2 (en) | 2015-02-19 | 2019-11-12 | Mymd Pharmaceuticals, Inc. | Method of treating addictions to opioids |
| US12472317B2 (en) | 2015-07-07 | 2025-11-18 | Altria Client Services Llc | E-vapor device including capsule containing pre-vapor formulation |
| US10874139B2 (en) | 2015-07-07 | 2020-12-29 | Altria Client Services Llc | E-vapor device including capsule containing pre-vapor formulation |
| CN105124763A (zh) * | 2015-09-06 | 2015-12-09 | 叶菁 | 非燃烧型低温卷烟用相变控温式燃料组件及其制备方法 |
| US10865001B2 (en) | 2016-02-11 | 2020-12-15 | Juul Labs, Inc. | Fillable vaporizer cartridge and method of filling |
| US10874137B2 (en) | 2016-02-27 | 2020-12-29 | Changzhou Jwei Intelligent Technology Co., Ltd. | Atomizer and electronic cigarette thereof |
| WO2017143953A1 (fr) * | 2016-02-27 | 2017-08-31 | 常州聚为智能科技有限公司 | Atomiseur et cigarette électronique correspondante |
| CN105559148A (zh) * | 2016-02-27 | 2016-05-11 | 卓尔悦(常州)电子科技有限公司 | 雾化器及其电子烟 |
| US10405582B2 (en) | 2016-03-10 | 2019-09-10 | Pax Labs, Inc. | Vaporization device with lip sensing |
| US20210007397A1 (en) * | 2016-05-31 | 2021-01-14 | Altria Client Services Llc | Refillable aerosol-generating article |
| US12023439B2 (en) * | 2016-05-31 | 2024-07-02 | Altria Client Services Llc | Refillable aerosol-generating article |
| WO2017210968A1 (fr) * | 2016-06-08 | 2017-12-14 | 卓尔悦(常州)电子科技有限公司 | Cigarette électronique |
| US10334887B1 (en) | 2016-06-08 | 2019-07-02 | Joyetech Europe Holding Gmbh | Atomizer and electronic cigarette |
| USD929036S1 (en) | 2016-06-16 | 2021-08-24 | Pax Labs, Inc. | Vaporizer cartridge and device assembly |
| USD849996S1 (en) | 2016-06-16 | 2019-05-28 | Pax Labs, Inc. | Vaporizer cartridge |
| USD913583S1 (en) | 2016-06-16 | 2021-03-16 | Pax Labs, Inc. | Vaporizer device |
| USD848057S1 (en) | 2016-06-23 | 2019-05-07 | Pax Labs, Inc. | Lid for a vaporizer |
| USD851830S1 (en) | 2016-06-23 | 2019-06-18 | Pax Labs, Inc. | Combined vaporizer tamp and pick tool |
| USD836541S1 (en) | 2016-06-23 | 2018-12-25 | Pax Labs, Inc. | Charging device |
| CN106072767A (zh) * | 2016-06-28 | 2016-11-09 | 卓尔悦欧洲控股有限公司 | 雾化头、雾化器及其电子烟 |
| USD842536S1 (en) | 2016-07-28 | 2019-03-05 | Juul Labs, Inc. | Vaporizer cartridge |
| USD825102S1 (en) | 2016-07-28 | 2018-08-07 | Juul Labs, Inc. | Vaporizer device with cartridge |
| JP2019531766A (ja) * | 2016-10-18 | 2019-11-07 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | eベイピング装置のプレベイパー製剤の安定性を改善するための方法およびシステム |
| JP7123949B2 (ja) | 2016-10-18 | 2022-08-23 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | eベイピング装置のプレベイパー製剤の安定性を増大させるための方法およびシステム |
| WO2018073261A1 (fr) * | 2016-10-18 | 2018-04-26 | Philip Morris Products S.A. | Procédés et systèmes destinés à améliorer la stabilité de la formulation de pré-vapeur d'un dispositif de vapotage électronique |
| KR102524201B1 (ko) * | 2016-10-18 | 2023-04-21 | 필립모리스 프로덕츠 에스.에이. | E-베이핑 장치의 기화전 제제의 안정성을 개선하기 위한 방법 및 시스템 |
| KR102604390B1 (ko) * | 2016-10-18 | 2023-11-21 | 필립모리스 프로덕츠 에스.에이. | E-베이핑 장치의 기화전 제제의 안정성을 증가시키기 위한 방법 및 시스템 |
| JP2019531097A (ja) * | 2016-10-18 | 2019-10-31 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | eベイピング装置のプレベイパー製剤の安定性を増大させるための方法およびシステム |
| KR20190062396A (ko) * | 2016-10-18 | 2019-06-05 | 필립모리스 프로덕츠 에스.에이. | E-베이핑 장치의 기화전 제제의 안정성을 증가시키기 위한 방법 및 시스템 |
| KR20190062398A (ko) * | 2016-10-18 | 2019-06-05 | 필립모리스 프로덕츠 에스.에이. | E-베이핑 장치의 기화전 제제의 안정성을 개선하기 위한 방법 및 시스템 |
| CN109788794A (zh) * | 2016-10-18 | 2019-05-21 | 菲利普莫里斯生产公司 | 用于提高电子蒸汽烟装置的蒸汽前调配物的稳定性的方法和系统 |
| WO2018176676A1 (fr) * | 2017-03-31 | 2018-10-04 | 纳智源科技(唐山)有限责任公司 | Dispositif et système de surveillance de quantité de fumée de tabac |
| USD887632S1 (en) | 2017-09-14 | 2020-06-16 | Pax Labs, Inc. | Vaporizer cartridge |
| USD927061S1 (en) | 2017-09-14 | 2021-08-03 | Pax Labs, Inc. | Vaporizer cartridge |
| US11819608B2 (en) | 2017-12-22 | 2023-11-21 | Nicoventures Trading Limited | Electronic aerosol provision system |
| US20220273019A1 (en) * | 2018-11-01 | 2022-09-01 | Nicoventures Trading Limited | Gel and crystalline powder |
| US12114689B2 (en) * | 2018-11-01 | 2024-10-15 | Nicoventures Trading Limited | Gel and crystalline powder |
| FR3089761A1 (fr) * | 2018-12-12 | 2020-06-19 | E-Rag | Composition liquide de cigarette électronique |
| CN113163845A (zh) * | 2018-12-31 | 2021-07-23 | 菲利普莫里斯生产公司 | 包含部分水溶性溶剂的液体尼古丁制剂 |
| US11992038B2 (en) | 2018-12-31 | 2024-05-28 | Philip Morris Products S.A. | Liquid nicotine formulation comprising partially water-soluble solvent |
| US12279647B2 (en) | 2019-12-23 | 2025-04-22 | Pax Labs, Inc. | Vaporizer cartridge |
| GB2595967A (en) * | 2020-05-01 | 2021-12-15 | Exhale Tech Ltd | Composition and use thereof |
| CN113208148A (zh) * | 2021-05-12 | 2021-08-06 | 云南中烟工业有限责任公司 | 一种协同释放尼古丁和致香成分的超分子凝胶 |
| USD1028336S1 (en) | 2021-06-22 | 2024-05-21 | Pax Labs, Inc. | Vaporizer cartridge |
| IT202100027086A1 (it) * | 2021-10-21 | 2023-04-21 | Alberto Patarchi | Erogatore portatile per il trattamento o la prevenzione di un’infezione o di una patologia causata da un virus |
| JP2023157820A (ja) * | 2022-04-15 | 2023-10-26 | 汪冶 | 霧化電子送達製品に用いられる霧化溶液 |
| JP7436587B2 (ja) | 2022-04-15 | 2024-02-21 | 汪冶 | 霧化電子送達製品に用いられる霧化溶液 |
| JP2023158617A (ja) * | 2022-04-18 | 2023-10-30 | 汪冶 | 加熱式非燃焼電子送達製品におけるアナバシンの使用、固体フレーク及びその製造方法 |
| JP7436590B2 (ja) | 2022-04-18 | 2024-02-21 | 汪冶 | 個体フレーク及びその製造方法 |
| CN115166070A (zh) * | 2022-06-16 | 2022-10-11 | 深圳萨特瓦生物科技有限公司 | 烟油或气溶胶中烟碱含量的测试方法及配制电子烟烟油的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20180184704A1 (en) | 2018-07-05 |
| WO2012177510A3 (fr) | 2013-02-28 |
| US20160050968A1 (en) | 2016-02-25 |
| WO2012177510A2 (fr) | 2012-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20180184704A1 (en) | Alkaloid Composition for E-Cigarette | |
| JP2024054280A (ja) | 複数相送達組成物及びそのような組成物を組み込んだ製品 | |
| WO2016133890A1 (fr) | Compositions pour cigarettes électroniques | |
| EP4268623A2 (fr) | Billes de tabac | |
| US20250302094A1 (en) | Interconnected active ingredient containing pouches | |
| IL279431B (en) | Compounds of tobacco products and delivery system | |
| WO2005018348A2 (fr) | Substitut de tabac a macher comprenant de la nicotine | |
| DK2552244T3 (en) | Inhibition of unwanted sensory effects with the camphor compound | |
| JP7148756B2 (ja) | 喫煙製品およびヴェポライザー用物品および製剤 | |
| US20130298921A1 (en) | Inhaler for smoking cessation | |
| EP3868222A1 (fr) | Article sans fumée | |
| US20130048001A1 (en) | Anatabine-Enriched Tobacco Products | |
| KR101257828B1 (ko) | 다마스콘 함유 금연보조제 조성물 | |
| WO2015009500A1 (fr) | Administration d'anatabine sous forme volatilisée pour le traitement d'une toxicomanie | |
| KR20090097069A (ko) | 휘발성 액상담배 니코틴의 조성물 | |
| JP7102590B1 (ja) | 電子タバコ用リキッド、および電子タバコ用リキッドの製造方法、ならびに電子タバコ用カートリッジ、電子タバコ | |
| KR102013417B1 (ko) | 금연초용 조성물 및 그 제조방법 | |
| US20060112965A1 (en) | Chewing tobacco substitute containing cotinine | |
| EP3868221A1 (fr) | Article sans fumée | |
| KR101002967B1 (ko) | 금연보조제 조성물 및 그 제조방법 | |
| EP4138585B1 (fr) | Formulation aérosolisable | |
| CN114568736A (zh) | 一种口含烟及其制备方法 | |
| JP3068084B1 (ja) | タバコ代用組成物 | |
| EP4627942A1 (fr) | Compositions et procédés | |
| EP4467010A1 (fr) | Produit en sachet et procédé de fabrication |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |